Core Insights - AstraZeneca PLC is preparing to announce a deal with U.S. President Donald Trump aimed at reducing drug prices, indicating a strategic alignment with government efforts to address pharmaceutical costs [1] Company Summary - The British drugmaker AstraZeneca is following the lead of Pfizer in engaging with the U.S. government to tackle drug pricing issues, which may enhance its market positioning and public perception [1]